Bone Metastasis with Superimposed Osteomyelitis in Prostate Cancer

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 999-1001

  Pruckmayer, Martha ^a,b   Glaser, Christoph ^a   Nasel, Christian ^a   Lang, Susanna ^a   Rasse, Michael ^a   Leitha, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antigranulocyte immunoscintigraphy; Bone metastases; Prostate cancer; SPECT

Indexed keywords

DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GRANULOCYTE; HUMAN; IMMUNOLOGY; JAW DISEASE; MALE; MANDIBLE TUMOR; METASTASIS; MIDDLE AGED; OSTEOMYELITIS; PATHOLOGY; PROSTATE TUMOR; RADIOGRAPHY; RADIOIMMUNOASSAY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIBODIES, MONOCLONAL; GRANULOCYTES; HUMANS; MALE; MANDIBULAR DISEASES; MANDIBULAR NEOPLASMS; MIDDLE AGED; OSTEOMYELITIS; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030162584     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Locher JT, Seybold K, Andres RY, Schubinger PA, Mach JP, Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal antigranulocytes antibodies. Nucl Med Commun 1986;7:659-670.
2. Seybold K, Locher JT, Coosemans C, Andres RY, Schubinger A, Bläuenstein P. Immunoscintigraphic localization of inflammatory lesions: Clinical experience. Eur J Nucl Med 1988;13:587-593.
3. Farid NA, White SM, Heck LL. Technetium-99m-labeled leukocytes: preparation and use in identification of abscesses and tissue rejection. Radiology 1983;148:827-831.
4. Bosslet K, Lüben G, Schwarz A, et al. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer 1985;36:75-79.
5. 99mTc-labeled monoclonal antibody. Eur J Nucl Med 1989;15:361-366.
6. 99mTc-labeled monoclonal antibodies: first clinical results. Nuc Compact 1987;18:223-229.
7. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med 1994;24:142-153.
8. 99mTc-labeled antigranulocyte antibodies. Nucl Med Commun 1993;14:212-218.
9. Lind P, Langsteger W, Koltringer P, Dimai HP, Passl R, Eber O. Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med 1990;31:417-423.
10. 99mTc-labeled monoclonal antibodies. Advanced experiences in 230 patients Angiology 1992;43:85-90.
11. 99mTc. Nucl Med Commun 1993;14:766-774.
12. Munz DL, Kornemann R, Brandhorst I, Hör G. Bone marrow scanning versus bone scanning in the early diagnosis of neoplastic involvement of the skeletal system. In: Schmidt HAE, Adam WE. Nuclear medicine: imaging of metabolisms and organ functions. Stuttgart: Schattauer; 1984:644.
13. Bathmann J, Moser E. Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases. Radiology 1995;35:8-14.
14. Reske S, Kartsens J, Sohn M, Glockner W, Buell L. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases. Acta Oncol 1993;32:753-761.
15. Otsuka N, Fukunaga M, Sone T, et al. The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer. Eur J Nucl Med 1985;11:319-322.
16. Sfakianakis GN, Mnaymneh W, Ghandur-Mnaymneh L, Al-Sheikh W, Hourani M, Heal A. Positive indium-111-leukocyte scintigraphy in a skeletal metastasis. Am J Radiol 1982;139:601-603.
17. Leitha T, Stümpflen A, Gebauer A, Amann G, Dudczak R. "False positive" immunoscintigraphic diagnosis of liver abscesses in a patient with a necrotic liver tumor. Eur J Nucl Med 1989;15:673-675.
18. 99mTc liver scans. Am J Radiol 1980;135:53-56.
19. Purnell DM, Heatfield BM, Trump BF. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin and prostate-specific antigen. Cancer Res 1984;44:285-292.
20. Frkovic-Grazio S, Kraljic I, Trnski D, Tarle M. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor. Anticancer Res 1994;14:2151-2156.
21. Tarle M. Serial measurements of tissue plypeptide-specific antigen, PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer. Anticancer Res 1993;13:769-777.
22. Friedman RB, Anderson RE, Entine SM, Shelley BH. Effects of disease on clinical laboratory tests. Clin Chem 1980;26:280D.